<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32</volume><submitter>Kim SH</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Several analgesics have been applied under various protocols to control the moderate-to-severe postoperative pain caused by the surgical extraction of an impacted mandibular third molar. However, a consensus on optimal pain management while minimizing side effects is yet to be reached.&lt;h4>Methods&lt;/h4>This multi-center, prospective, double-blind, randomized controlled trial aims to evaluate the efficacy and safety of sequential multimodal analgesia combined with postoperative zaltoprofen along with multiple preemptive analgesics. A total of 80 participants with bilateral impacted mandibular third molar from two hospitals were randomized into two groups. Two surgical extractions were performed at one-month intervals, and in a crossover design, celecoxib or tramadol/acetaminophen was administered before one extraction and placebo before the other extraction. Following extraction, all subjects took zaltoprofen for 5 days. The outcome measures included pain at specific times, time and intensity of the first pain onset after extraction, need of rescue drugs, and occurrence and frequency of side effects.&lt;h4>Conclusions&lt;/h4>This ongoing clinical trial was designed to provide evidence regarding a new protocol for effective postoperative pain management of a commonly performed surgical extraction. The results of this study will provide guidance to clinicians regarding the timing and combination of oral analgesics in various oral surgeries performed under local anesthesia.&lt;h4>Trial registration&lt;/h4>KCT0005450, registered on October 7, 2020.</pubmed_abstract><journal>Contemporary clinical trials communications</journal><pagination>101078</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9905937</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Application of sequential multimodal analgesia before and after impacted mandibular third molar extraction: Protocol for a randomized controlled trial.</pubmed_title><pmcid>PMC9905937</pmcid><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Kim SH</pubmed_authors><pubmed_authors>Song MK</pubmed_authors><pubmed_authors>Kang JY</pubmed_authors><pubmed_authors>Kim YS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Application of sequential multimodal analgesia before and after impacted mandibular third molar extraction: Protocol for a randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>Several analgesics have been applied under various protocols to control the moderate-to-severe postoperative pain caused by the surgical extraction of an impacted mandibular third molar. However, a consensus on optimal pain management while minimizing side effects is yet to be reached.&lt;h4>Methods&lt;/h4>This multi-center, prospective, double-blind, randomized controlled trial aims to evaluate the efficacy and safety of sequential multimodal analgesia combined with postoperative zaltoprofen along with multiple preemptive analgesics. A total of 80 participants with bilateral impacted mandibular third molar from two hospitals were randomized into two groups. Two surgical extractions were performed at one-month intervals, and in a crossover design, celecoxib or tramadol/acetaminophen was administered before one extraction and placebo before the other extraction. Following extraction, all subjects took zaltoprofen for 5 days. The outcome measures included pain at specific times, time and intensity of the first pain onset after extraction, need of rescue drugs, and occurrence and frequency of side effects.&lt;h4>Conclusions&lt;/h4>This ongoing clinical trial was designed to provide evidence regarding a new protocol for effective postoperative pain management of a commonly performed surgical extraction. The results of this study will provide guidance to clinicians regarding the timing and combination of oral analgesics in various oral surgeries performed under local anesthesia.&lt;h4>Trial registration&lt;/h4>KCT0005450, registered on October 7, 2020.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-18T21:17:07.627Z</modification><creation>2025-04-07T09:16:38.784Z</creation></dates><accession>S-EPMC9905937</accession><cross_references><pubmed>36762120</pubmed><doi>10.1016/j.conctc.2023.101078</doi></cross_references></HashMap>